NCT02914951
Cognitive-Behavioral Therapy for Irritability in Children With Autism Spectrum Disorder and Intellectual Disability
Enrolling by Invitation
NAAges 8–16InterventionalTreatmentYale UniversityInvestigator-initiated
~6 participants
Updated 2026-05-08 on ClinicalTrials.gov
What's tested:Cognitive-Behavioral TherapyFunctional magnetic resonance imaging (fMRI)
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Modified Overt Aggression Scale (MOAS)
Measured over Weekly - up to 20 weeks
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesConnecticut1
Study leadership
- Denis Sukhodolsky, PhD · PRINCIPAL_INVESTIGATOR · Associate Professor
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
DSM-5 diagnosis of Autism Spectrum Disorder
Presence of disruptive behaviors such as irritability and anger outbursts
IQ between 55 and 85
ABC Irritability Scale score greater than or equal to 15
Un-medicated or on stable medication regimen
Able to complete all study assessment and fMRI procedures
Exclusion
Medical or psychiatric condition that would require alternative treatment
What this trial measures
- Modified Overt Aggression Scale (MOAS)Weekly - up to 20 weeks
Modified Overt Aggression Scale (MOAS) is a 16-item scale that reflects the frequency and severity of incidents of aggressive behavior
- Aberrant Behavior Checklist - Irritability Scale (ABC-I)Weekly - up to 20 weeks
The ABC-I is a 15-item parent rating of irritability that has been commonly used in clinical trials in children with ASD.